 Duncan Wilcox
Concepts (516)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 25 | 2023 | 162 | 5.020 |
Why?
| | Cloaca | 16 | 2023 | 48 | 3.470 |
Why?
| | Urologic Surgical Procedures | 16 | 2022 | 94 | 2.990 |
Why?
| | Hypospadias | 7 | 2022 | 26 | 2.930 |
Why?
| | Urinary Bladder Neck Obstruction | 5 | 2023 | 20 | 2.380 |
Why?
| | Urogenital Abnormalities | 9 | 2023 | 48 | 2.290 |
Why?
| | Lower Urinary Tract Symptoms | 5 | 2021 | 47 | 1.820 |
Why?
| | Anorectal Malformations | 9 | 2023 | 103 | 1.790 |
Why?
| | Urinary Bladder, Neurogenic | 5 | 2022 | 30 | 1.750 |
Why?
| | Urethra | 10 | 2020 | 48 | 1.720 |
Why?
| | Hydronephrosis | 5 | 2015 | 28 | 1.570 |
Why?
| | Urogenital System | 4 | 2023 | 18 | 1.500 |
Why?
| | Urology | 7 | 2023 | 46 | 1.480 |
Why?
| | Urodynamics | 5 | 2019 | 28 | 1.470 |
Why?
| | Ureteral Obstruction | 5 | 2022 | 54 | 1.370 |
Why?
| | Urinary Bladder, Overactive | 2 | 2021 | 20 | 1.330 |
Why?
| | Spinal Dysraphism | 6 | 2017 | 42 | 1.310 |
Why?
| | Kidney | 13 | 2023 | 1188 | 1.190 |
Why?
| | Circumcision, Male | 2 | 2019 | 17 | 1.100 |
Why?
| | Infant | 47 | 2022 | 7961 | 1.080 |
Why?
| | Lactams, Macrocyclic | 2 | 2017 | 46 | 1.080 |
Why?
| | Benzoquinones | 2 | 2017 | 44 | 1.070 |
Why?
| | Urologic Surgical Procedures, Male | 3 | 2022 | 27 | 1.060 |
Why?
| | Urinary Tract | 5 | 2016 | 36 | 1.050 |
Why?
| | Postoperative Complications | 18 | 2023 | 2128 | 1.040 |
Why?
| | Pain, Postoperative | 4 | 2020 | 191 | 1.010 |
Why?
| | Hernias, Diaphragmatic, Congenital | 15 | 1998 | 186 | 1.010 |
Why?
| | Hernia, Diaphragmatic | 13 | 2000 | 67 | 0.950 |
Why?
| | Male | 87 | 2023 | 55583 | 0.900 |
Why?
| | Child | 58 | 2023 | 18412 | 0.900 |
Why?
| | Reoperation | 10 | 2018 | 514 | 0.890 |
Why?
| | Hirschsprung Disease | 8 | 2022 | 90 | 0.880 |
Why?
| | Child, Preschool | 41 | 2020 | 9114 | 0.870 |
Why?
| | Tocotrienols | 1 | 2023 | 3 | 0.850 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 225 | 0.850 |
Why?
| | Urination | 4 | 2022 | 40 | 0.850 |
Why?
| | Urologic Diseases | 5 | 2018 | 35 | 0.840 |
Why?
| | Postoperative Care | 3 | 2019 | 222 | 0.820 |
Why?
| | Rectum | 7 | 2023 | 153 | 0.820 |
Why?
| | Muscle, Smooth | 4 | 2017 | 144 | 0.800 |
Why?
| | Humans | 133 | 2023 | 114662 | 0.790 |
Why?
| | Penis | 3 | 2019 | 37 | 0.780 |
Why?
| | Urinary Bladder Diseases | 4 | 2022 | 18 | 0.770 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 35 | 0.760 |
Why?
| | Anger | 1 | 2021 | 55 | 0.740 |
Why?
| | Kidney Pelvis | 3 | 2022 | 20 | 0.730 |
Why?
| | Urinary Incontinence | 4 | 2015 | 56 | 0.730 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2021 | 19 | 0.730 |
Why?
| | Anal Canal | 6 | 2023 | 84 | 0.730 |
Why?
| | Cystostomy | 3 | 2017 | 8 | 0.720 |
Why?
| | TRPV Cation Channels | 1 | 2021 | 31 | 0.720 |
Why?
| | Constipation | 1 | 2021 | 76 | 0.690 |
Why?
| | Retrospective Studies | 43 | 2023 | 12546 | 0.690 |
Why?
| | Calcium Channels | 1 | 2021 | 145 | 0.680 |
Why?
| | Female | 80 | 2023 | 59493 | 0.680 |
Why?
| | Follow-Up Studies | 23 | 2018 | 4411 | 0.670 |
Why?
| | Ureter | 5 | 2019 | 31 | 0.630 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2018 | 4 | 0.620 |
Why?
| | Cholinergic Fibers | 1 | 2018 | 16 | 0.620 |
Why?
| | Receptors, Muscarinic | 1 | 2018 | 17 | 0.620 |
Why?
| | Cryptorchidism | 4 | 2023 | 11 | 0.620 |
Why?
| | Photography | 1 | 2019 | 89 | 0.620 |
Why?
| | Laparoscopy | 6 | 2022 | 398 | 0.610 |
Why?
| | Intestine, Large | 1 | 2018 | 13 | 0.610 |
Why?
| | Genitalia, Female | 2 | 2018 | 37 | 0.610 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2012 | 22 | 0.600 |
Why?
| | Muscle Contraction | 2 | 2019 | 389 | 0.600 |
Why?
| | Vagina | 3 | 2023 | 146 | 0.580 |
Why?
| | Perioperative Care | 2 | 2018 | 127 | 0.580 |
Why?
| | Preoperative Care | 3 | 2011 | 319 | 0.570 |
Why?
| | Treatment Outcome | 23 | 2022 | 9088 | 0.570 |
Why?
| | Fecal Incontinence | 5 | 2018 | 73 | 0.570 |
Why?
| | Anesthetics, Local | 2 | 2015 | 81 | 0.570 |
Why?
| | Urination Disorders | 2 | 2015 | 11 | 0.570 |
Why?
| | Pulmonary Surfactants | 9 | 2000 | 99 | 0.560 |
Why?
| | Infant, Newborn | 28 | 2020 | 5045 | 0.530 |
Why?
| | Clitoris | 1 | 2016 | 8 | 0.520 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2015 | 3 | 0.500 |
Why?
| | Ultrasonography, Prenatal | 7 | 2014 | 236 | 0.500 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2011 | 31 | 0.480 |
Why?
| | Nephrectomy | 5 | 2009 | 150 | 0.460 |
Why?
| | Gastrointestinal Diseases | 1 | 2016 | 182 | 0.460 |
Why?
| | Prospective Studies | 14 | 2023 | 6219 | 0.460 |
Why?
| | Recovery of Function | 1 | 2018 | 574 | 0.460 |
Why?
| | Colon | 4 | 2023 | 233 | 0.450 |
Why?
| | Infusion Pumps | 1 | 2013 | 31 | 0.450 |
Why?
| | Animals | 29 | 2023 | 31698 | 0.440 |
Why?
| | Creatinine | 1 | 2015 | 425 | 0.440 |
Why?
| | Enema | 2 | 2006 | 38 | 0.420 |
Why?
| | Cadherins | 1 | 2014 | 175 | 0.420 |
Why?
| | Paraphimosis | 1 | 2012 | 1 | 0.410 |
Why?
| | Abnormalities, Multiple | 5 | 2006 | 178 | 0.410 |
Why?
| | Pediatrics | 3 | 2017 | 979 | 0.410 |
Why?
| | Bandages | 1 | 2012 | 31 | 0.400 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 771 | 0.400 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 249 | 0.400 |
Why?
| | Diagnostic Techniques, Urological | 1 | 2012 | 5 | 0.400 |
Why?
| | Age Factors | 9 | 2019 | 2894 | 0.390 |
Why?
| | Radioisotope Renography | 1 | 2011 | 4 | 0.390 |
Why?
| | Edema | 1 | 2012 | 119 | 0.380 |
Why?
| | Surgical Sponges | 1 | 2011 | 3 | 0.380 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4692 | 0.380 |
Why?
| | Adolescent | 35 | 2023 | 17841 | 0.370 |
Why?
| | Guideline Adherence | 1 | 2015 | 490 | 0.370 |
Why?
| | Stents | 1 | 2014 | 475 | 0.370 |
Why?
| | Dissection | 1 | 2011 | 51 | 0.360 |
Why?
| | Incidence | 6 | 2023 | 2313 | 0.360 |
Why?
| | Disease Models, Animal | 10 | 2018 | 3532 | 0.360 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 486 | 0.350 |
Why?
| | Transition to Adult Care | 2 | 2023 | 62 | 0.350 |
Why?
| | Registries | 1 | 2018 | 1768 | 0.350 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 152 | 0.340 |
Why?
| | Fetal Diseases | 3 | 2007 | 147 | 0.330 |
Why?
| | Wilms Tumor | 3 | 2017 | 68 | 0.330 |
Why?
| | Bladder Exstrophy | 5 | 2007 | 15 | 0.330 |
Why?
| | Sexual Dysfunction, Physiological | 2 | 2009 | 60 | 0.330 |
Why?
| | Cystitis | 1 | 2009 | 20 | 0.320 |
Why?
| | Doxorubicin | 2 | 2021 | 285 | 0.320 |
Why?
| | Signal Transduction | 2 | 2021 | 4512 | 0.320 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 248 | 0.310 |
Why?
| | Mice | 12 | 2023 | 14863 | 0.310 |
Why?
| | Urethral Diseases | 3 | 2020 | 18 | 0.310 |
Why?
| | Ileum | 2 | 2006 | 90 | 0.310 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2011 | 498 | 0.310 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2005 | 28 | 0.300 |
Why?
| | Ureterocele | 1 | 2007 | 7 | 0.300 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 85 | 0.300 |
Why?
| | Digestive System Abnormalities | 2 | 2004 | 12 | 0.300 |
Why?
| | Pulmonary Gas Exchange | 4 | 1998 | 117 | 0.290 |
Why?
| | Prenatal Diagnosis | 5 | 2007 | 167 | 0.280 |
Why?
| | Colon, Sigmoid | 5 | 2021 | 15 | 0.280 |
Why?
| | Cathartics | 1 | 2006 | 11 | 0.270 |
Why?
| | Urography | 1 | 2006 | 13 | 0.270 |
Why?
| | Urinary Bladder Fistula | 2 | 2022 | 10 | 0.270 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 73 | 0.270 |
Why?
| | Vesicovaginal Fistula | 1 | 2005 | 3 | 0.260 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 615 | 0.260 |
Why?
| | Kidney Function Tests | 4 | 2015 | 140 | 0.250 |
Why?
| | Mass Screening | 1 | 2012 | 1004 | 0.240 |
Why?
| | Animals, Newborn | 6 | 2018 | 778 | 0.240 |
Why?
| | Kidney Neoplasms | 2 | 2009 | 327 | 0.240 |
Why?
| | Hemorrhage | 1 | 2009 | 620 | 0.240 |
Why?
| | Vincristine | 2 | 2022 | 98 | 0.230 |
Why?
| | Postnatal Care | 2 | 2015 | 65 | 0.230 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 52 | 0.230 |
Why?
| | Prognosis | 5 | 2018 | 3329 | 0.220 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 12 | 0.220 |
Why?
| | Length of Stay | 5 | 2023 | 962 | 0.220 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2022 | 120 | 0.220 |
Why?
| | Fetus | 1 | 2007 | 700 | 0.220 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 511 | 0.210 |
Why?
| | Lung | 6 | 1998 | 3559 | 0.210 |
Why?
| | Ultrasonography | 4 | 2015 | 634 | 0.210 |
Why?
| | Urinary Diversion | 3 | 2015 | 11 | 0.210 |
Why?
| | Sacrum | 1 | 2003 | 65 | 0.200 |
Why?
| | Surgical Flaps | 1 | 2003 | 121 | 0.200 |
Why?
| | Muscle Development | 1 | 2003 | 98 | 0.200 |
Why?
| | Pain Measurement | 2 | 2015 | 444 | 0.200 |
Why?
| | Kidney Calices | 1 | 2001 | 1 | 0.200 |
Why?
| | Analgesia | 2 | 2020 | 82 | 0.190 |
Why?
| | Sheep | 11 | 1998 | 764 | 0.190 |
Why?
| | Cell Hypoxia | 3 | 2014 | 220 | 0.190 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 127 | 0.190 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 91 | 0.190 |
Why?
| | Testicular Neoplasms | 2 | 2019 | 96 | 0.190 |
Why?
| | Pregnancy Outcome | 2 | 2022 | 337 | 0.190 |
Why?
| | Gastrostomy | 2 | 1999 | 91 | 0.180 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2020 | 10 | 0.180 |
Why?
| | Robotics | 1 | 2022 | 75 | 0.180 |
Why?
| | Hydrocephalus | 2 | 2011 | 83 | 0.180 |
Why?
| | Administration, Oral | 1 | 2023 | 728 | 0.180 |
Why?
| | Risk Assessment | 5 | 2017 | 2968 | 0.180 |
Why?
| | Intestinal Obstruction | 3 | 1997 | 40 | 0.180 |
Why?
| | Colitis, Ulcerative | 2 | 2021 | 105 | 0.180 |
Why?
| | Prune Belly Syndrome | 2 | 2011 | 7 | 0.170 |
Why?
| | Orchiopexy | 1 | 2019 | 4 | 0.170 |
Why?
| | Cell Division | 1 | 2002 | 758 | 0.170 |
Why?
| | Perinatology | 1 | 1999 | 6 | 0.170 |
Why?
| | Hypertrophy | 2 | 2019 | 109 | 0.170 |
Why?
| | Smooth Muscle Myosins | 1 | 2019 | 7 | 0.160 |
Why?
| | Diet | 1 | 2006 | 1080 | 0.160 |
Why?
| | Nephrology Nursing | 1 | 2019 | 5 | 0.160 |
Why?
| | Muscle Relaxation | 1 | 2019 | 19 | 0.160 |
Why?
| | Nephrology | 1 | 1999 | 48 | 0.160 |
Why?
| | Myosin Light Chains | 1 | 2019 | 26 | 0.160 |
Why?
| | Atlases as Topic | 1 | 2019 | 9 | 0.160 |
Why?
| | Nephrostomy, Percutaneous | 1 | 1999 | 9 | 0.160 |
Why?
| | Extracellular Matrix | 1 | 2003 | 436 | 0.160 |
Why?
| | Pediatric Nursing | 1 | 2019 | 39 | 0.160 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 604 | 0.160 |
Why?
| | Pilot Projects | 2 | 2023 | 1373 | 0.160 |
Why?
| | Anxiety, Separation | 1 | 2018 | 16 | 0.160 |
Why?
| | Sex Factors | 4 | 2017 | 1715 | 0.160 |
Why?
| | Umbilicus | 1 | 1998 | 14 | 0.160 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 109 | 0.160 |
Why?
| | Maternal Deprivation | 1 | 2018 | 15 | 0.160 |
Why?
| | Twins, Conjoined | 1 | 1998 | 5 | 0.150 |
Why?
| | Kidney Diseases | 4 | 2009 | 350 | 0.150 |
Why?
| | Phospholipids | 2 | 1997 | 197 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2019 | 149 | 0.150 |
Why?
| | Medical Errors | 1 | 2019 | 85 | 0.150 |
Why?
| | Reflex | 1 | 2018 | 64 | 0.150 |
Why?
| | Reference Values | 2 | 2018 | 743 | 0.150 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 126 | 0.150 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 1997 | 7 | 0.150 |
Why?
| | Time Factors | 6 | 2019 | 6114 | 0.150 |
Why?
| | Phosphatidylcholines | 2 | 1997 | 133 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2020 | 3003 | 0.150 |
Why?
| | Urinary Catheterization | 2 | 2001 | 23 | 0.150 |
Why?
| | Informed Consent | 1 | 1998 | 161 | 0.140 |
Why?
| | Cancer Survivors | 1 | 2021 | 205 | 0.140 |
Why?
| | Algorithms | 3 | 2018 | 1468 | 0.140 |
Why?
| | Genitalia, Male | 1 | 1997 | 10 | 0.140 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 25 | 0.140 |
Why?
| | Peptic Ulcer Perforation | 1 | 1997 | 2 | 0.140 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1997 | 5 | 0.140 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 6 | 0.140 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 243 | 0.140 |
Why?
| | Duodenal Ulcer | 1 | 1997 | 10 | 0.140 |
Why?
| | Catheterization | 2 | 2013 | 159 | 0.140 |
Why?
| | Cholelithiasis | 1 | 1997 | 31 | 0.140 |
Why?
| | Gallstones | 1 | 1997 | 28 | 0.140 |
Why?
| | Postoperative Period | 1 | 2018 | 289 | 0.140 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1518 | 0.130 |
Why?
| | Risk Factors | 3 | 2018 | 8632 | 0.130 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2017 | 196 | 0.130 |
Why?
| | Endoscopy | 1 | 1998 | 246 | 0.130 |
Why?
| | Patient Safety | 1 | 2019 | 277 | 0.130 |
Why?
| | Vulva | 1 | 2016 | 24 | 0.130 |
Why?
| | Fluorocarbons | 1 | 1997 | 94 | 0.130 |
Why?
| | Outpatients | 1 | 2019 | 326 | 0.130 |
Why?
| | Adult | 14 | 2023 | 30544 | 0.130 |
Why?
| | Young Adult | 8 | 2023 | 10466 | 0.130 |
Why?
| | Medical Oncology | 1 | 2017 | 229 | 0.120 |
Why?
| | Pneumothorax | 1 | 1995 | 42 | 0.120 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 44 | 0.120 |
Why?
| | Phosphatidylglycerols | 1 | 1995 | 20 | 0.120 |
Why?
| | Sphingomyelins | 1 | 1995 | 26 | 0.120 |
Why?
| | Infusion Pumps, Implantable | 1 | 2015 | 20 | 0.120 |
Why?
| | Testis | 2 | 2023 | 133 | 0.120 |
Why?
| | Toothbrushing | 1 | 1994 | 6 | 0.120 |
Why?
| | Attitude to Health | 1 | 1998 | 406 | 0.120 |
Why?
| | Lung Compliance | 2 | 1995 | 47 | 0.120 |
Why?
| | Bulimia | 1 | 1994 | 19 | 0.120 |
Why?
| | Amniotic Fluid | 1 | 1995 | 64 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2002 | 1700 | 0.120 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 1692 | 0.120 |
Why?
| | Desmin | 2 | 2006 | 31 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1430 | 0.120 |
Why?
| | Bone and Bones | 1 | 1997 | 278 | 0.120 |
Why?
| | Appendix | 3 | 2001 | 27 | 0.120 |
Why?
| | Scrotum | 2 | 2007 | 23 | 0.120 |
Why?
| | Triiodothyronine | 1 | 1994 | 42 | 0.120 |
Why?
| | Laparotomy | 1 | 1994 | 103 | 0.120 |
Why?
| | Organ Size | 2 | 2014 | 434 | 0.110 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 385 | 0.110 |
Why?
| | ROC Curve | 2 | 2015 | 442 | 0.110 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 371 | 0.110 |
Why?
| | Meconium | 1 | 1993 | 7 | 0.110 |
Why?
| | Pregnancy | 10 | 2022 | 5518 | 0.110 |
Why?
| | Anastomosis, Surgical | 5 | 2020 | 136 | 0.110 |
Why?
| | Respiration, Artificial | 1 | 1997 | 529 | 0.110 |
Why?
| | Foreign Bodies | 1 | 1994 | 96 | 0.110 |
Why?
| | Phenyl Ethers | 1 | 1993 | 3 | 0.110 |
Why?
| | Logistic Models | 1 | 2018 | 1841 | 0.110 |
Why?
| | Foreign-Body Migration | 2 | 2011 | 37 | 0.110 |
Why?
| | Perineum | 2 | 2019 | 25 | 0.110 |
Why?
| | Nitric Oxide | 2 | 1997 | 823 | 0.110 |
Why?
| | Apoptosis | 1 | 2002 | 2362 | 0.100 |
Why?
| | Foreskin | 1 | 2012 | 5 | 0.100 |
Why?
| | Fertility | 2 | 2022 | 130 | 0.100 |
Why?
| | Comorbidity | 2 | 2016 | 1448 | 0.100 |
Why?
| | Syndrome | 2 | 2007 | 333 | 0.100 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 167 | 0.100 |
Why?
| | Fetal Blood | 1 | 1994 | 270 | 0.100 |
Why?
| | Infant Food | 1 | 1993 | 63 | 0.100 |
Why?
| | Hydrocortisone | 1 | 1994 | 267 | 0.100 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 3 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2538 | 0.100 |
Why?
| | Shock | 1 | 1993 | 84 | 0.100 |
Why?
| | Metabolism, Inborn Errors | 1 | 2011 | 39 | 0.100 |
Why?
| | Genitalia | 2 | 2019 | 28 | 0.090 |
Why?
| | Pain Management | 1 | 2013 | 288 | 0.090 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1796 | 0.090 |
Why?
| | Parents | 1 | 1998 | 1186 | 0.090 |
Why?
| | Databases, Factual | 3 | 2019 | 1125 | 0.090 |
Why?
| | Hernia, Ventral | 1 | 2010 | 18 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2011 | 257 | 0.080 |
Why?
| | Ischemia | 1 | 1993 | 362 | 0.080 |
Why?
| | Acute Disease | 1 | 2012 | 911 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 535 | 0.080 |
Why?
| | Urinary Reservoirs, Continent | 2 | 2016 | 4 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1629 | 0.080 |
Why?
| | Campomelic Dysplasia | 1 | 2009 | 2 | 0.080 |
Why?
| | Dysgerminoma | 1 | 2009 | 3 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 208 | 0.080 |
Why?
| | BK Virus | 1 | 2009 | 14 | 0.080 |
Why?
| | Urolithiasis | 1 | 2009 | 8 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 1 | 2009 | 36 | 0.080 |
Why?
| | Polyomavirus Infections | 1 | 2009 | 22 | 0.080 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 23 | 0.080 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 43 | 0.080 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 1997 | 590 | 0.080 |
Why?
| | Cohort Studies | 2 | 2016 | 4895 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2380 | 0.080 |
Why?
| | Ureterostomy | 1 | 2007 | 3 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 239 | 0.070 |
Why?
| | Nanoparticles | 1 | 2011 | 313 | 0.070 |
Why?
| | Neoplasms | 1 | 2021 | 2097 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 668 | 0.070 |
Why?
| | Liver Neoplasms | 1 | 2011 | 506 | 0.070 |
Why?
| | Pulmonary Artery | 4 | 1997 | 1015 | 0.070 |
Why?
| | Urogenital Neoplasms | 1 | 2006 | 5 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 140 | 0.070 |
Why?
| | Myogenin | 1 | 2006 | 11 | 0.070 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2006 | 16 | 0.070 |
Why?
| | Calcinosis | 1 | 2009 | 242 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2009 | 1226 | 0.070 |
Why?
| | Hematocolpos | 1 | 2005 | 3 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 215 | 0.060 |
Why?
| | Fetal Organ Maturity | 2 | 1995 | 26 | 0.060 |
Why?
| | Malabsorption Syndromes | 1 | 2004 | 15 | 0.060 |
Why?
| | Defecation | 1 | 2004 | 17 | 0.060 |
Why?
| | Nutritional Support | 1 | 2004 | 27 | 0.060 |
Why?
| | Gestational Age | 3 | 2004 | 760 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1394 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3408 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2009 | 388 | 0.060 |
Why?
| | Salvage Therapy | 1 | 2004 | 127 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2007 | 355 | 0.060 |
Why?
| | Menstruation Disturbances | 1 | 2003 | 12 | 0.060 |
Why?
| | Rabbits | 2 | 1996 | 733 | 0.060 |
Why?
| | Coitus | 1 | 2003 | 27 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4622 | 0.060 |
Why?
| | Urologists | 1 | 2023 | 17 | 0.050 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2003 | 30 | 0.050 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 14 | 0.050 |
Why?
| | Urethral Obstruction | 1 | 2003 | 9 | 0.050 |
Why?
| | Methyl Green | 1 | 2003 | 1 | 0.050 |
Why?
| | Colostomy | 3 | 2004 | 26 | 0.050 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2003 | 7 | 0.050 |
Why?
| | Ascites | 1 | 2003 | 32 | 0.050 |
Why?
| | Urine | 1 | 2003 | 54 | 0.050 |
Why?
| | Azo Compounds | 1 | 2003 | 25 | 0.050 |
Why?
| | Urothelium | 1 | 2003 | 33 | 0.050 |
Why?
| | Blood Pressure | 4 | 1997 | 1538 | 0.050 |
Why?
| | Erectile Dysfunction | 1 | 2022 | 38 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2015 | 2763 | 0.050 |
Why?
| | Puberty | 1 | 2003 | 135 | 0.050 |
Why?
| | Endocrinology | 1 | 2003 | 70 | 0.050 |
Why?
| | Observer Variation | 1 | 2003 | 295 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2007 | 284 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2003 | 108 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 49 | 0.050 |
Why?
| | Epispadias | 1 | 2001 | 3 | 0.050 |
Why?
| | Dilatation, Pathologic | 2 | 2001 | 55 | 0.050 |
Why?
| | Ureteral Diseases | 1 | 2001 | 3 | 0.050 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.050 |
Why?
| | Proteolipids | 2 | 2000 | 28 | 0.050 |
Why?
| | Learning Curve | 1 | 2022 | 63 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2007 | 795 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2023 | 740 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2285 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2022 | 413 | 0.040 |
Why?
| | Urinary Fistula | 1 | 2000 | 9 | 0.040 |
Why?
| | Radiography | 1 | 2003 | 812 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 250 | 0.040 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2000 | 31 | 0.040 |
Why?
| | Blotting, Western | 1 | 2003 | 1147 | 0.040 |
Why?
| | Intestines | 2 | 2020 | 326 | 0.040 |
Why?
| | Gastric Fistula | 1 | 1999 | 4 | 0.040 |
Why?
| | Jejunal Diseases | 1 | 1999 | 7 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1999 | 11 | 0.040 |
Why?
| | Actins | 1 | 2002 | 381 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 9 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 9 | 0.040 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2019 | 19 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 56 | 0.040 |
Why?
| | Pulmonary Alveoli | 2 | 2000 | 373 | 0.040 |
Why?
| | Quality of Life | 1 | 2009 | 2353 | 0.040 |
Why?
| | Pelvis | 1 | 1999 | 90 | 0.040 |
Why?
| | Digestive System Diseases | 1 | 1998 | 23 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 19 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 19 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 25 | 0.040 |
Why?
| | Mutation | 1 | 2009 | 3345 | 0.040 |
Why?
| | Drainage | 1 | 1999 | 151 | 0.040 |
Why?
| | Cecostomy | 1 | 1998 | 3 | 0.040 |
Why?
| | Surgical Stomas | 1 | 1998 | 6 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2003 | 640 | 0.040 |
Why?
| | Surgical Mesh | 1 | 1998 | 40 | 0.040 |
Why?
| | Capillaries | 1 | 1998 | 91 | 0.040 |
Why?
| | Sigmoid Diseases | 1 | 1997 | 10 | 0.040 |
Why?
| | Survival Analysis | 2 | 2017 | 1211 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 1997 | 72 | 0.040 |
Why?
| | Cardiology Service, Hospital | 1 | 1997 | 28 | 0.040 |
Why?
| | Rats | 2 | 1996 | 4958 | 0.030 |
Why?
| | Ampulla of Vater | 1 | 1997 | 30 | 0.030 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 54 | 0.030 |
Why?
| | Ileal Diseases | 1 | 1996 | 9 | 0.030 |
Why?
| | Duodenum | 1 | 1997 | 62 | 0.030 |
Why?
| | Rectal Neoplasms | 2 | 1998 | 121 | 0.030 |
Why?
| | Stomach | 1 | 1997 | 102 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 92 | 0.030 |
Why?
| | Barrett Esophagus | 1 | 1999 | 147 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1143 | 0.030 |
Why?
| | Collagen | 2 | 1995 | 415 | 0.030 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 1995 | 132 | 0.030 |
Why?
| | Umbilical Cord | 1 | 1996 | 80 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 106 | 0.030 |
Why?
| | Wound Healing | 1 | 1998 | 258 | 0.030 |
Why?
| | Clinical Protocols | 1 | 1997 | 233 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 620 | 0.030 |
Why?
| | United States | 1 | 2011 | 12181 | 0.030 |
Why?
| | NADPH Dehydrogenase | 1 | 1995 | 8 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 18 | 0.030 |
Why?
| | Middle Aged | 5 | 2021 | 26733 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1569 | 0.030 |
Why?
| | Tunica Intima | 1 | 1995 | 78 | 0.030 |
Why?
| | Proteins | 3 | 1995 | 908 | 0.030 |
Why?
| | Swine | 1 | 1996 | 700 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 651 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 531 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 30 | 0.030 |
Why?
| | Bupivacaine | 1 | 1994 | 31 | 0.030 |
Why?
| | Thoracotomy | 1 | 1994 | 75 | 0.030 |
Why?
| | Heart Diseases | 1 | 1997 | 331 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 61 | 0.030 |
Why?
| | Disease Management | 1 | 2017 | 560 | 0.030 |
Why?
| | Sigmoid Neoplasms | 1 | 1993 | 3 | 0.030 |
Why?
| | Gangrene | 1 | 1993 | 6 | 0.030 |
Why?
| | Hypertonic Solutions | 1 | 1993 | 7 | 0.030 |
Why?
| | Product Labeling | 1 | 1993 | 5 | 0.030 |
Why?
| | Ileostomy | 2 | 2004 | 18 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 1997 | 414 | 0.030 |
Why?
| | Recurrence | 1 | 1995 | 935 | 0.030 |
Why?
| | Necrosis | 1 | 1993 | 211 | 0.020 |
Why?
| | Colorado | 2 | 2018 | 4099 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2011 | 12 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2011 | 27 | 0.020 |
Why?
| | Consanguinity | 1 | 2011 | 46 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 152 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2011 | 62 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 314 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 147 | 0.020 |
Why?
| | Colitis | 1 | 1993 | 223 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2000 | 241 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 578 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1995 | 671 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2114 | 0.020 |
Why?
| | Chronic Disease | 1 | 1993 | 1578 | 0.020 |
Why?
| | Tissue Survival | 1 | 2007 | 13 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 32 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 126 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 86 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 152 | 0.020 |
Why?
| | Microsurgery | 1 | 2007 | 59 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 1998 | 1728 | 0.020 |
Why?
| | Vaginal Neoplasms | 1 | 2006 | 11 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1369 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2006 | 61 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 1121 | 0.020 |
Why?
| | Hydroxyproline | 2 | 1995 | 22 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2011 | 2568 | 0.020 |
Why?
| | Elastin | 2 | 1995 | 78 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2710 | 0.010 |
Why?
| | Duodenal Obstruction | 1 | 2004 | 5 | 0.010 |
Why?
| | Short Bowel Syndrome | 1 | 2004 | 20 | 0.010 |
Why?
| | Parenteral Nutrition, Total | 1 | 2004 | 27 | 0.010 |
Why?
| | Intestinal Atresia | 1 | 2004 | 16 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1342 | 0.010 |
Why?
| | Enteritis | 1 | 2004 | 82 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1083 | 0.010 |
Why?
| | Gender Identity | 1 | 2003 | 102 | 0.010 |
Why?
| | Europe | 1 | 2003 | 334 | 0.010 |
Why?
| | Aorta | 2 | 1995 | 386 | 0.010 |
Why?
| | Consensus | 1 | 2003 | 537 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 869 | 0.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2000 | 101 | 0.010 |
Why?
| | Societies, Medical | 1 | 2003 | 663 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 921 | 0.010 |
Why?
| | Glycoproteins | 1 | 2000 | 304 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 446 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 3885 | 0.010 |
Why?
| | DNA | 2 | 1995 | 1352 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 1998 | 30 | 0.010 |
Why?
| | Leiomyoma | 1 | 1998 | 44 | 0.010 |
Why?
| | Blood-Air Barrier | 1 | 1998 | 10 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 159 | 0.010 |
Why?
| | Esophagoscopy | 1 | 1999 | 184 | 0.010 |
Why?
| | Venous Thrombosis | 1 | 1998 | 140 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2002 | 489 | 0.010 |
Why?
| | Constriction | 1 | 1996 | 45 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1996 | 49 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 1997 | 244 | 0.010 |
Why?
| | Venules | 1 | 1995 | 13 | 0.010 |
Why?
| | Heart Septum | 1 | 1995 | 26 | 0.010 |
Why?
| | Arterioles | 1 | 1995 | 39 | 0.010 |
Why?
| | Pneumonia | 1 | 2000 | 567 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1036 | 0.010 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1995 | 50 | 0.010 |
Why?
| | Heart Septal Defects, Atrial | 1 | 1995 | 51 | 0.010 |
Why?
| | Heart Atria | 1 | 1995 | 107 | 0.010 |
Why?
| | Pleura | 1 | 1994 | 18 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 1995 | 209 | 0.010 |
Why?
| | Bronchi | 1 | 1995 | 231 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 683 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1995 | 511 | 0.010 |
Why?
| | Hospital Mortality | 1 | 1997 | 776 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 1995 | 641 | 0.010 |
Why?
| | Heparin | 1 | 1994 | 224 | 0.010 |
Why?
| | Echocardiography | 1 | 1994 | 553 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 712 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1999 | 955 | 0.010 |
Why?
| | Aged | 2 | 1997 | 19069 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1993 | 6345 | 0.000 |
Why?
|
|
Wilcox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|